DK0478602T3 - Ekspression af tetanus toxin fragment C - Google Patents
Ekspression af tetanus toxin fragment CInfo
- Publication number
- DK0478602T3 DK0478602T3 DK90909052.4T DK90909052T DK0478602T3 DK 0478602 T3 DK0478602 T3 DK 0478602T3 DK 90909052 T DK90909052 T DK 90909052T DK 0478602 T3 DK0478602 T3 DK 0478602T3
- Authority
- DK
- Denmark
- Prior art keywords
- tetanus toxin
- expression
- toxin fragment
- fragment
- mature fragment
- Prior art date
Links
- 108010044241 tetanus toxin fragment C Proteins 0.000 title 1
- 108010055044 Tetanus Toxin Proteins 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 229940118376 tetanus toxin Drugs 0.000 abstract 2
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898914122A GB8914122D0 (en) | 1989-06-20 | 1989-06-20 | Polypeptide expression |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0478602T3 true DK0478602T3 (da) | 1996-02-05 |
Family
ID=10658724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK90909052.4T DK0478602T3 (da) | 1989-06-20 | 1990-06-20 | Ekspression af tetanus toxin fragment C |
Country Status (9)
Country | Link |
---|---|
US (1) | US5443966A (da) |
EP (1) | EP0478602B1 (da) |
JP (1) | JP2981286B2 (da) |
AT (1) | ATE132532T1 (da) |
DE (1) | DE69024652T2 (da) |
DK (1) | DK0478602T3 (da) |
ES (1) | ES2084030T3 (da) |
GB (1) | GB8914122D0 (da) |
WO (1) | WO1990015871A1 (da) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5601826A (en) * | 1989-06-30 | 1997-02-11 | The United States Of America As Represented By The Department Of Health And Human Services | Peptide which produces protective immunity against tetanus |
GB9209118D0 (en) * | 1992-04-28 | 1992-06-10 | Sb 120 Amsterdam Bv | Vaccine compositions |
WO1994000487A1 (en) * | 1992-06-30 | 1994-01-06 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Peptide which produces protective immunity against tetanus |
AU4719393A (en) * | 1992-07-31 | 1994-03-03 | Medeva Holdings B.V. | Expression of recombinant fusion proteins in attenuated bacteria |
GB9401787D0 (en) * | 1994-01-31 | 1994-03-23 | Medeva Holdings Bv | Vaccine compositions |
US20030185792A1 (en) * | 1996-01-22 | 2003-10-02 | Curis, Inc. | Morphogen analogs of bone morphogenic proteins |
CA2244228A1 (en) * | 1996-01-22 | 1997-07-24 | Creative Biomolecules, Inc. | Morphogen analogs and methods for producing them |
US6372225B1 (en) | 1996-03-23 | 2002-04-16 | The Research Foundation Of Microbial Diseases Of Osaka University | Tetanus toxin functional fragment antigen and tetanus vaccine |
US5958469A (en) * | 1997-05-14 | 1999-09-28 | Eastman Kodak Company | Method for fabricating tools for molding diffractive surfaces on optical lenses |
DK1049712T3 (da) * | 1997-08-14 | 2007-05-29 | Pasteur Institut | Hybrid-tetanus-toxoid-proteiner der retrogradt og transsynaptisk migrerer ind i CNS |
US7923216B2 (en) * | 1997-08-14 | 2011-04-12 | Institut Pasteur | In vivo modulation of neuronal transport |
US20100081197A1 (en) * | 1997-08-14 | 2010-04-01 | Sylvie Roux | In vivo modulation of neuronal transport |
GB0108364D0 (en) | 2001-04-03 | 2001-05-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
US20030180316A1 (en) | 2000-06-29 | 2003-09-25 | Dominique Boutriau | Multivalent vaccine composition |
US20070105799A1 (en) * | 2002-09-10 | 2007-05-10 | Vical Incorporated | Codon-optimized polynucleotide-based vaccines against Bacillus anthracis infection |
US7972608B2 (en) * | 2003-06-23 | 2011-07-05 | Baxter International Inc. | Carrier proteins for vaccines |
US20070092449A1 (en) * | 2005-04-05 | 2007-04-26 | Rafael Vazquez-Martinez | Methods for direct visualization of active synapses |
EP1790358A1 (en) * | 2005-11-23 | 2007-05-30 | Université de Reims Champagne-Ardennes | Protein constructs designed for targeting and lysis of cells |
AU2007293672B2 (en) | 2006-09-07 | 2013-06-27 | Glaxosmithkline Biologicals S.A. | Vaccine |
KR20100017569A (ko) | 2007-05-02 | 2010-02-16 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 백신 |
CA2793978C (en) | 2010-03-30 | 2021-08-03 | Pfenex Inc. | High level expression of recombinant toxin proteins |
CA2799470A1 (en) | 2010-05-14 | 2011-11-17 | The Children's Hospital Of Philadelphia | Humanized ttc and methods of use thereof |
GB201105981D0 (en) | 2011-04-08 | 2011-05-18 | Glaxosmithkline Biolog Sa | Novel process |
EP2788021B1 (en) | 2011-12-09 | 2017-01-18 | Bavarian Nordic A/S | Poxvirus vector for the expression of bacterial antigens linked to tetanus toxin fragment c |
US9169304B2 (en) | 2012-05-01 | 2015-10-27 | Pfenex Inc. | Process for purifying recombinant Plasmodium falciparum circumsporozoite protein |
MY172181A (en) | 2013-03-08 | 2019-11-15 | Janssen Vaccines & Prevention Bv | Acellular pertussis vaccine |
WO2016001762A1 (en) | 2014-07-02 | 2016-01-07 | Spherium Biomed S.L. | Methods of increasing muscle mass using non-toxic tetanus toxin c fragment (ttc) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2355094C3 (de) * | 1973-11-03 | 1979-05-23 | Behringwerke Ag, 3550 Marburg | Verfahren zur Herstellung eines Tetanus-Impfstoffs |
GB8516442D0 (en) * | 1985-06-28 | 1985-07-31 | Wellcome Found | Cloned antigen |
-
1989
- 1989-06-20 GB GB898914122A patent/GB8914122D0/en active Pending
-
1990
- 1990-06-20 WO PCT/GB1990/000943 patent/WO1990015871A1/en active IP Right Grant
- 1990-06-20 DE DE69024652T patent/DE69024652T2/de not_active Expired - Lifetime
- 1990-06-20 AT AT90909052T patent/ATE132532T1/de not_active IP Right Cessation
- 1990-06-20 EP EP90909052A patent/EP0478602B1/en not_active Expired - Lifetime
- 1990-06-20 ES ES90909052T patent/ES2084030T3/es not_active Expired - Lifetime
- 1990-06-20 DK DK90909052.4T patent/DK0478602T3/da active
- 1990-06-20 JP JP2508664A patent/JP2981286B2/ja not_active Expired - Lifetime
-
1993
- 1993-08-23 US US08/110,786 patent/US5443966A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2981286B2 (ja) | 1999-11-22 |
EP0478602B1 (en) | 1996-01-03 |
DE69024652T2 (de) | 1996-05-15 |
JPH04506005A (ja) | 1992-10-22 |
GB8914122D0 (en) | 1989-08-09 |
DE69024652D1 (de) | 1996-02-15 |
ATE132532T1 (de) | 1996-01-15 |
US5443966A (en) | 1995-08-22 |
WO1990015871A1 (en) | 1990-12-27 |
ES2084030T3 (es) | 1996-05-01 |
EP0478602A1 (en) | 1992-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0478602T3 (da) | Ekspression af tetanus toxin fragment C | |
DK0652758T3 (da) | Diferitoxin-vacciner | |
YU47525B (sh) | Zeleno staklo za apsorpciju infracrvenog i ultravioletnog zračenja i automobilsko staklo izradjeno od istog | |
ATE93271T1 (de) | Vakzine. | |
FI933888A (fi) | Aertproteinhydrolysat, foerfarande foer dess framstaellning och anvaendningdaerav | |
DK0663010T3 (da) | Fremgangsmåde til forøgelse af sekretion af overudtrykte proteiner | |
FI952148A (fi) | Geenitekninen menetelmä ja isäntä ksylitolin valmistamiseksi | |
DE59308000D1 (de) | Immunoassay zum nachweis von kollagen oder kollagenfragmenten | |
SE9201544L (sv) | Saett att framstaella glykosyltransferaser | |
MY107819A (en) | Preparation of substituted piperidines. | |
IT1211116B (it) | Procedimento per lapreparazione di 4'-deossi-daunorubicina 4'-deossi-doxorubicina. | |
DE59407306D1 (de) | Kontinuierlicher prozess zur herstellung von tertiären alkoholen durch radikalische additionsreaktion von sekundären alkoholen an alkene | |
ATE81136T1 (de) | Immunogenes produkt, erhalten durch expression in einer rekombinanten hefe, und verfahren zu seiner reinigung. | |
NZ239249A (en) | Pure gelonin toxin and its corresponding dna sequence | |
NO913078L (no) | Oekt proteinproduksjon i dyr. | |
ES2023560A6 (es) | Procedimiento para la produccion de hidrato de cefradina y solvato de cefradina y dimetilformamida. | |
ATE194624T1 (de) | Mutanten von menschlichem antithrombin iii | |
KR950700684A (ko) | 시클릭 항-종양 촉진제 화합물, 그의 조성물, 제조 방법 및 용도(Cyclic Anti-Tumor Promoter Compounds, Compositions and Methods for Production and Use) | |
DK0536564T3 (da) | Fremgangsmåde til fremstilling af streptolysin O, intakt streptolysin O fremstillet ved denne fremgangsmåde og dets anvendelse | |
DK0456986T3 (da) | Varmeresistent beta-galactosyltransferase, fremtillingsfremgangsmåde herfor og anvendelse heraf | |
DK0421749T3 (da) | 3-aroyl-2-oxindol-1-carboxamider | |
NO843750L (no) | Immuninterferon og fremgangsmaate ved fremstilling derav | |
JPS53141262A (en) | Coriolin derivative and process for their preparation | |
DK0592574T3 (da) | Fremgangsmåde til fremstilling af rekombinante proteiner og værtsceller anvendt derved | |
SU1672636A1 (ru) | Адъювант для производства противоящурной вакцины |